Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Environmental and social factors impacting on epidemic and endemic tuberculosis: a modelling analysis.

Issarow CM, Mulder N, Wood R.

R Soc Open Sci. 2018 Jan 17;5(1):170726. doi: 10.1098/rsos.170726. eCollection 2018 Jan.

2.

Tuberculosis: Just the FAQs.

Guinn KM, Rubin EJ.

MBio. 2017 Dec 19;8(6). pii: e01910-17. doi: 10.1128/mBio.01910-17.

3.

Seasonality of active tuberculosis notification from 2005 to 2014 in Xinjiang, China.

Wubuli A, Li Y, Xue F, Yao X, Upur H, Wushouer Q.

PLoS One. 2017 Jul 5;12(7):e0180226. doi: 10.1371/journal.pone.0180226. eCollection 2017.

4.

Migration to middle-income countries and tuberculosis-global policies for global economies.

Pescarini JM, Rodrigues LC, Gomes MG, Waldman EA.

Global Health. 2017 Mar 15;13(1):15. doi: 10.1186/s12992-017-0236-6.

5.

Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Jagielski T, Minias A, van Ingen J, Rastogi N, Brzostek A, Żaczek A, Dziadek J.

Clin Microbiol Rev. 2016 Apr;29(2):239-90. doi: 10.1128/CMR.00055-15. Review.

6.

Plan Beta for tuberculosis: it's time to think seriously about poorly ventilated congregate settings.

Yates TA, Tanser F, Abubakar I.

Int J Tuberc Lung Dis. 2016 Jan;20(1):5-10. doi: 10.5588/ijtld.15.0494.

7.

Transmission of Mycobacterium tuberculosis in China: a population-based molecular epidemiologic study.

Yang C, Shen X, Peng Y, Lan R, Zhao Y, Long B, Luo T, Sun G, Li X, Qiao K, Gui X, Wu J, Xu J, Li F, Li D, Liu F, Shen M, Hong J, Mei J, DeRiemer K, Gao Q.

Clin Infect Dis. 2015 Jul 15;61(2):219-27. doi: 10.1093/cid/civ255. Epub 2015 Mar 31.

8.

Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy.

Vynnycky E, Sumner T, Fielding KL, Lewis JJ, Cox AP, Hayes RJ, Corbett EL, Churchyard GJ, Grant AD, White RG.

Am J Epidemiol. 2015 Apr 15;181(8):619-32. doi: 10.1093/aje/kwu320. Epub 2015 Mar 19.

9.

Molecular epidemiology of Mycobacterium tuberculosis among South African gold miners.

Mathema B, Lewis JJ, Connors J, Chihota VN, Shashkina E, van der Meulen M, Graviss EA, Ha NP, Kreiswirth BN, Grant AD, Fielding KL, Dorman SE, Churchyard GJ.

Ann Am Thorac Soc. 2015 Jan;12(1):12-20. doi: 10.1513/AnnalsATS.201404-150OC.

10.

Molecular Epidemiology Analysis of TB in Five Regional States of Iran.

Ravan P, Farnia P, Amirmozafari N, Taghavi K, Ahmadi M, Masjedi MR, Velayati AA.

Tanaffos. 2013;12(1):26-30.

11.

Tuberculosis screening in high human immunodeficiency virus prevalence settings: turning promise into reality.

Corbett EL, MacPherson P.

Int J Tuberc Lung Dis. 2013 Sep;17(9):1125-38. doi: 10.5588/ijtld.13.0117. Review.

12.

Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list'.

Dowdy DW, Dye C, Cohen T.

Int J Tuberc Lung Dis. 2013 Jul;17(7):866-77. doi: 10.5588/ijtld.12.0573. Review.

13.

Spatial dependency of tuberculosis incidence in Taiwan.

Ng IC, Wen TH, Wang JY, Fang CT.

PLoS One. 2012;7(11):e50740. doi: 10.1371/journal.pone.0050740. Epub 2012 Nov 30.

14.

Long term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting.

Johnston J, Admon A, Ibrahim A, Elwood K, Tang P, Cook V, Fitzgerald M.

BMC Infect Dis. 2012 Oct 22;12:266. doi: 10.1186/1471-2334-12-266.

15.

Infectious disease risk in asbestos abatement workers.

Lange JH, Mastrangelo G, Cegolon L.

BMC Public Health. 2012 Aug 16;12:665. doi: 10.1186/1471-2458-12-665.

16.

Genetic determinants of drug-resistant tuberculosis among HIV-infected patients in Nigeria.

Dinic L, Akande P, Idigbe EO, Ani A, Onwujekwe D, Agbaji O, Akanbi M, Nwosu R, Adeniyi B, Wahab M, Lekuk C, Kunle-Ope C, Nwokoye N, Kanki P.

J Clin Microbiol. 2012 Sep;50(9):2905-9. doi: 10.1128/JCM.00982-12. Epub 2012 Jun 27.

17.

Mycobacterium tuberculosis complex drug resistance pattern and identification of species causing tuberculosis in the West and Centre regions of Cameroon.

Assam-Assam JP, Penlap VB, Cho-Ngwa F, Tedom JC, Ane-Anyangwe I, Titanji VP.

BMC Infect Dis. 2011 Apr 15;11:94. doi: 10.1186/1471-2334-11-94.

18.

Addressing institutional amplifiers in the dynamics and control of tuberculosis epidemics.

Basu S, Stuckler D, McKee M.

Am J Trop Med Hyg. 2011 Jan;84(1):30-7. doi: 10.4269/ajtmh.2011.10-0472.

19.

Clustering of Mycobacterium tuberculosis cases in Acapulco: Spoligotyping and risk factors.

Nava-Aguilera E, López-Vidal Y, Harris E, Morales-Pérez A, Mitchell S, Flores-Moreno M, Villegas-Arrizón A, Legorreta-Soberanis J, Ledogar R, Andersson N.

Clin Dev Immunol. 2011;2011:408375. doi: 10.1155/2011/408375. Epub 2010 Dec 8.

20.

Community-randomized trial of enhanced DOTS for tuberculosis control in Rio de Janeiro, Brazil.

Cavalcante SC, Durovni B, Barnes GL, Souza FB, Silva RF, Barroso PF, Mohan CI, Miller A, Golub JE, Chaisson RE.

Int J Tuberc Lung Dis. 2010 Feb;14(2):203-9.

Supplemental Content

Support Center